Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing

AJ Gehring, KM Dobos, JT Belisle… - The Journal of …, 2004 - journals.aai.org
AJ Gehring, KM Dobos, JT Belisle, CV Harding, WH Boom
The Journal of immunology, 2004journals.aai.org
Abstract MHC class II (MHC-II)-restricted CD4+ T cells are essential for control of
Mycobacterium tuberculosis infection. This report describes the identification and purification
of LprG (Rv1411c) as an inhibitor of primary human macrophage MHC-II Ag processing.
LprG is a 24-kDa lipoprotein found in the M. tuberculosis cell wall. Prolonged exposure (> 16
h) of human macrophages to LprG resulted in marked inhibition of MHC-II Ag processing.
Inhibition of MHC-II Ag processing was dependent on TLR-2. Short-term exposure (< 6 h) to …
Abstract
MHC class II (MHC-II)-restricted CD4+ T cells are essential for control of Mycobacterium tuberculosis infection. This report describes the identification and purification of LprG (Rv1411c) as an inhibitor of primary human macrophage MHC-II Ag processing. LprG is a 24-kDa lipoprotein found in the M. tuberculosis cell wall. Prolonged exposure (> 16 h) of human macrophages to LprG resulted in marked inhibition of MHC-II Ag processing. Inhibition of MHC-II Ag processing was dependent on TLR-2. Short-term exposure (< 6 h) to LprG stimulated TLR-2-dependent TNF-α production. Thus, LprG can exploit TLR-2 signaling to inhibit MHC-II Ag processing in human macrophages. Inhibition of MHC-II Ag processing by mycobacterial lipoproteins may allow M. tuberculosis, within infected macrophages, to avoid recognition by CD4+ T cells.
journals.aai.org